Skip to main content
. Author manuscript; available in PMC: 2014 May 9.
Published in final edited form as: Cancer Control. 2012 Jul;19(3):227–235. doi: 10.1177/107327481201900307

Fig 2.

Fig 2

Treatment approaches in MCL. Treatment in the young has steadily progressed with regards to intensity with the goal of molecular eradication of disease. Treatment in the elderly, alternatively has stressed treatment tolerance with the application of novel agents for maintenance and in relapsed settings.